These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 3755395)
1. 1,25-Dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs. Malluche HH; Matthews C; Faugere MC; Fanti P; Endres DB; Friedler RM Endocrinology; 1986 Sep; 119(3):1298-304. PubMed ID: 3755395 [TBL] [Abstract][Full Text] [Related]
2. Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats. Szabó A; Freesmeyer MG; Abendroth K; Stein G; Rosivall L; El-Shakmak A; Ritz E Eur J Clin Invest; 1999 Jun; 29(6):529-35. PubMed ID: 10354215 [TBL] [Abstract][Full Text] [Related]
3. The effects of 1,25-dihydroxycholecalciferol, parathyroid hormone, and thyroxine on trabecular bone remodeling in adult dogs. A histomorphometric study. High WB; Capen CC; Black HE Am J Pathol; 1981 Dec; 105(3):279-87. PubMed ID: 6895577 [TBL] [Abstract][Full Text] [Related]
4. Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone. Galceran T; Martin KJ; Morrissey JJ; Slatopolsky E Kidney Int; 1987 Dec; 32(6):801-7. PubMed ID: 3430963 [TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
6. Bioactive parathyroid hormone in the rat: effects of calcium and calcitriol. Seshadri MS; Frankel TL; Lissner D; Mason RS; Posen S Endocrinology; 1985 Dec; 117(6):2417-23. PubMed ID: 3840736 [TBL] [Abstract][Full Text] [Related]
7. Infusions of parathyroid hormone in ruminants: hypercalcemia and reduced plasma 1,25-dihydroxyvitamin D concentrations. Hove K; Horst RL; Littledike ET; Beitz DC Endocrinology; 1984 Mar; 114(3):897-903. PubMed ID: 6546544 [TBL] [Abstract][Full Text] [Related]
8. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids. Russell J; Bar A; Sherwood LM; Hurwitz S Endocrinology; 1993 Jun; 132(6):2639-44. PubMed ID: 8389284 [TBL] [Abstract][Full Text] [Related]
9. Histomorphometric evaluation of the effects of low dose parathyroid hormone administration on cortical bone remodeling in adult dogs. High WB; Black HE; Capen CC Lab Invest; 1981 May; 44(5):449-54. PubMed ID: 7230731 [TBL] [Abstract][Full Text] [Related]
10. 1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis. Kinoshita Y; Taguchi M; Takeshita A; Miura D; Tomikawa S; Takeuchi Y J Clin Endocrinol Metab; 2005 Dec; 90(12):6727-31. PubMed ID: 16159932 [TBL] [Abstract][Full Text] [Related]
11. The effect of vitamin D on bone in vivo. Tam CS; Heersche JN; Jones G; Murray TM; Rasmussen H Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118 [TBL] [Abstract][Full Text] [Related]
12. Exogenous PTH and endogenous 1,25-dihydroxyvitamin D are complementary in inducing an anabolic effect on bone. Samadfam R; Xia Q; Miao D; Hendy GN; Goltzman D J Bone Miner Res; 2008 Aug; 23(8):1257-66. PubMed ID: 18348699 [TBL] [Abstract][Full Text] [Related]
13. Adaptation of parathyroid function to intravenous 1,25-dihydroxyvitamin D3 or partial parathyroidectomy in normal dogs. Cloutier M; Gagnon Y; Gascon-Barré M; Brossard JH; D'Amour P J Endocrinol; 1997 Oct; 155(1):133-41. PubMed ID: 9390015 [TBL] [Abstract][Full Text] [Related]
14. Vitamin D and bone. Suda T; Ueno Y; Fujii K; Shinki T J Cell Biochem; 2003 Feb; 88(2):259-66. PubMed ID: 12520524 [TBL] [Abstract][Full Text] [Related]
15. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Xue Y; Karaplis AC; Hendy GN; Goltzman D; Miao D Hum Mol Genet; 2005 Jun; 14(11):1515-28. PubMed ID: 15843402 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D physiology. Lips P Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471 [TBL] [Abstract][Full Text] [Related]
17. In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH. Ueno Y; Shinki T; Nagai Y; Murayama H; Fujii K; Suda T J Cell Biochem; 2003 Oct; 90(2):267-77. PubMed ID: 14505343 [TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone sensitizes long bones to the stimulation of bone resorption by 1,25-dihydroxyvitamin D3. van Leeuwen JP; Birkenhäger JC; Bos MP; van der Bemd GJ; Herrmann-Erlee MP; Pols HA J Bone Miner Res; 1992 Mar; 7(3):303-9. PubMed ID: 1585831 [TBL] [Abstract][Full Text] [Related]
19. Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor. Leloup G; Lemoine P; Carmeliet P; Vaes G J Bone Miner Res; 1996 Aug; 11(8):1146-57. PubMed ID: 8854251 [TBL] [Abstract][Full Text] [Related]
20. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]